Nephrolithiasis in PHPT
Journal Title: Journal of Medical Sciences - Year 2018, Vol 21, Issue 2
Abstract
Primary hyperparathyroidism (PHPT) is a common disorder and is the third most common endocrine disorder after diabetes mellitus and thyroid disorders. This common endocrine disorder has scaled down into an asymptomatic disease revealed by routine biochemical evaluation of patients for a variety of skeletal and non-skeletal symptoms in much of the western world. However, in India, and similar developing regions of world it continues to be for the most part an overtly symptomatic disease with skeletal, renal and other organ system manifestations.
Authors and Affiliations
Reyaz A Misgar, Arshad I Wani
Management and outcome of hepatitis B reactivation in immunocompromised patients
INTRODUCTION: Hepatitis B virus reactivation(HBVR) is known to occur in cancer patients receiving chemotherapy. HBVR has high rate of mortality even after treatment. MATERIAL AND METHODS: This prospective study was cond...
Ovarian Inguinal Herniation
A 3 days female newborn, born at term by Cesarean section, with a birth weight of 3200 g, was brought to the casualty with the complaints of irritability and a lump in her right groin by her mother. On physical examinati...
Sweat Analysis and Cystic Fibrosis: A Golden Handshake
Cystic fibrosis (CF) is one of the most lethal, autosomal recessive, monogenic disorder that presents as a multisystem disease with significant morbidity and mortality in all parts of the world caused due to an abnormal...
Effect of cilostazol on claudication distances and lipid profile in patients with occlusive peripheral arterial disease: A placebo controlled trial
Objectives(s): To study the efficacy and tolerability of cilostazol in patients with moderately severe peripheral arterial disease. Study Design: Randomized, open label, placebo controlled parallel study. Methods: It i...
Clinical Trial Regulations In India : Past, Present and Future
Clinical trials are the only way of establishing the safety and efficacy of any new drug before its introduction in the market for human use. Clinical trials (with safeguards) are necessary for the introduction of new dr...